Literature DB >> 19481941

Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases.

Sabine Linz1, Jörg Müller, Harald Hübner, Peter Gmeiner, Reinhard Troschütz.   

Abstract

A series of phenylpiperazine-methyl-substituted 1H-pyrrolo[2,3-c]pyridine, imidazo[1,2-c]-, pyrrolo[2,3-d]- and pyrrolo[3,2-d]pyrimidines were prepared as selective dopamine D4-ligands. The pyrrolo[2,3-d]pyrimidine derivatives 12d (K(i)=1,9 nM) and 34 d (K(i)=2,4 nM) as well as the pyrrolo[3,2-d]pyrimidine Mannich base 49f (K(i)=2,8 nM) showed high dopamine D4 receptor activity superior to the atypical antipsychotic agent clozapine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481941     DOI: 10.1016/j.bmc.2009.05.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

Review 1.  Mannich bases in medicinal chemistry and drug design.

Authors:  Gheorghe Roman
Journal:  Eur J Med Chem       Date:  2014-10-30       Impact factor: 6.514

2.  Novel Substituted Purine Isosteres: Synthesis, Structure-Activity Relationships and Cytotoxic Activity Evaluation.

Authors:  Spyridon Dimitrakis; Efthymios-Spyridon Gavriil; Athanasios Pousias; Nikolaos Lougiakis; Panagiotis Marakos; Nicole Pouli; Katerina Gioti; Roxane Tenta
Journal:  Molecules       Date:  2021-12-31       Impact factor: 4.411

3.  Identification of Novel Dopamine D2 Receptor Ligands-A Combined In Silico/In Vitro Approach.

Authors:  Lukas Zell; Constanze Lainer; Jakub Kollár; Veronika Temml; Daniela Schuster
Journal:  Molecules       Date:  2022-07-11       Impact factor: 4.927

4.  Synthesis and Structure-Activity Relationships of Imidazopyridine/Pyrimidine- and Furopyridine-Based Anti-infective Agents against Trypanosomiases.

Authors:  Daniel G Silva; Anna Junker; Shaiani M G de Melo; Fernando Fumagalli; J Robert Gillespie; Nora Molasky; Frederick S Buckner; An Matheeussen; Guy Caljon; Louis Maes; Flavio S Emery
Journal:  ChemMedChem       Date:  2020-11-11       Impact factor: 3.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.